This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: No defined compartments |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile RegulatedAuthorization.
Generated Narrative: RegulatedAuthorization
Resource RegulatedAuthorization "basic-drug-auth"
subject: MedicinalProductDefinition/equilidem
type: Regulatory Drug Marketing Approval ()
status: active ([not stated]#active)
statusDate: 2016-01-01
holder: Organization/EqlidrugCo: EquiliDrugCo Holdings Inc.
regulator: Organization/FDA: FDA
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.